Boston Scientific Corporation (BSX) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Devices secteur d'activité. Le siège social de l'entreprise est situé à Marlborough, MA, United States. Le PDG actuel est Michael F. Mahoney.
BSX a date d'introduction en bourse 1992-05-19, 53,000 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $94.85B.
Boston Scientific Corporation is a global medical device manufacturer that develops, manufactures, and markets innovative devices across interventional medical specialties. Operating through three primary segments—MedSurg, Rhythm and Neuro, and Cardiovascular—the company serves diverse therapeutic areas including gastrointestinal and pulmonary diagnostics, urology, cardiac rhythm management, neurostimulation, and interventional cardiology. Its comprehensive product portfolio encompasses implantable cardiac devices, ablation systems, coronary stents, peripheral vascular interventions, and oncology treatment solutions. Headquartered in Marlborough, Massachusetts, Boston Scientific has established itself as a leading provider of minimally invasive medical technologies that improve patient outcomes across multiple healthcare markets worldwide.
